Cabal-Hierro, Lucia
van Galen, Peter https://orcid.org/0000-0002-0735-1570
Prado, Miguel A. https://orcid.org/0000-0002-4914-1619
Higby, Kelly J.
Togami, Katsuhiro
Mowery, Cody T. https://orcid.org/0000-0003-2939-013X
Paulo, Joao A. https://orcid.org/0000-0002-4291-413X
Xie, Yingtian
Cejas, Paloma
Furusawa, Takashi
Bustin, Michael https://orcid.org/0000-0002-5147-7242
Long, Henry W. https://orcid.org/0000-0001-6849-6629
Sykes, David B.
Gygi, Steven P.
Finley, Daniel
Bernstein, Bradley E. https://orcid.org/0000-0002-5726-6278
Lane, Andrew A. https://orcid.org/0000-0001-7380-0226
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA181340, CA225191, CA218832)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Leukemia and Lymphoma Society
Alex's Lemonade Stand Foundation for Childhood Cancer
Harvard University | Harvard Stem Cell Institute
Anna Fuller Fund, AIM 2 Cure, Curing Kids Cancer
Article History
Received: 8 November 2019
Accepted: 27 February 2020
First Online: 16 March 2020
Competing interests
: A.A.L. has received research funding from AbbVie and Stemline Therapeutics and serves as a consultant for N-of-One/Qiagen.